Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Rani Therapeutics Holdings, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −3 vs. Q1 2024
- Shares held
- 3.11M
- −345.3K (−10.0%) vs. Q1 2024
- Total value
- $11.8M
- +$1.07M (+9.9%) vs. Q1 2024
- New holders
- 3
- 10 more added
- Sold out
- 6
- 7 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RANI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 68 | $34.7M |
| Q1 2026 | 74 | $31.4M |
| Q4 2025 | 64 | $60.5M |
| Q3 2025 | 38 | $2.02M |
| Q2 2025 | 39 | $3.32M |
| Q1 2025 | 38 | $4.58M |
| Q4 2024 | 42 | $5.23M |
| Q3 2024 | 31 | $12.8M |
| Q2 2024 | 34 | $11.8M |
| Q1 2024 | 37 | $10.7M |
| Q4 2023 | 34 | $10.9M |
| Q3 2023 | 34 | $6.96M |
| Q2 2023 | 35 | $13.3M |
| Q1 2023 | 36 | $15.5M |
| Q4 2022 | 34 | $17.6M |
| Q3 2022 | 32 | $30.4M |
| Q2 2022 | 28 | $29.1M |
| Q1 2022 | 24 | $34.5M |
| Q4 2021 | 22 | $20.3M |
| Q3 2021 | 15 | $19.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Rani Therapeutics Holdings, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 12 | $0 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 3 | $12 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 71 | $270 | 0.00% | −12,615−99.4% | Reduced |
| Rhumbline Advisers | 312 | $1.19K | 0.00% | 00.0% | Unchanged |
| Belvedere Trading LLC | 991 | $3.77K | 0.00% | +991 | New |
| Simplex Trading, LLC | 1,482 | $5.00K | 0.00% | +118+8.7% | Added |
| The PNC Financial Services Group, Inc. | 2,000 | $7.60K | 0.00% | −7,116−78.1% | Reduced |
| Allworth Financial LP | 3,119 | $9.61K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,951 | $11.2K | 0.00% | +500+20.4% | Added |
| UBS Group AG | 3,000 | $11.4K | 0.00% | 00.0% | Unchanged |
| Islay Capital Management, LLC | 9,611 | $36.5K | 0.03% | 00.0% | Unchanged |
| Virtu Financial LLC | 10,153 | $39.0K | 0.00% | +10,153 | New |
| Prime Capital Investment Advisors, LLC | 13,882 | $52.8K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 14,437 | $54.9K | 0.00% | +13,198+1,065.2% | Added |
| Citadel Advisors LLC | 14,765 | $56.1K | 0.00% | +4,733+47.2% | Added |
| Lafayette Investments, Inc. | 19,893 | $75.6K | 0.02% | 00.0% | Unchanged |
| Marshall Wace, LLP | 21,247 | $80.7K | 0.00% | +21,247 | New |
| Renaissance Technologies LLC | 21,700 | $82.5K | 0.00% | −48,600−69.1% | Reduced |
| Brown Advisory Inc | 32,911 | $125.1K | 0.00% | −1,000−2.9% | Reduced |
| Northern Trust Corp | 35,306 | $134.2K | 0.00% | +9,318+35.9% | Added |
| State Street Corp | 42,042 | $159.8K | 0.00% | +8,300+24.6% | Added |
| Motco | 48,129 | $182.9K | 0.01% | 00.0% | Unchanged |
| King Luther Capital Management Corp | 56,129 | $213.3K | 0.00% | 00.0% | Unchanged |
| Lasry Marc | 62,887 | $239.0K | 0.24% | 00.0% | Unchanged |
| BlackRock Inc. | 63,583 | $241.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 71,500 | $271.7K | 0.01% | +20,000+38.8% | Added |
| Bank of America Corp | 91,846 | $349.0K | 0.00% | −32,659−26.2% | Reduced |
| Stifel Financial Corp | 134,620 | $511.6K | 0.00% | +2,186+1.7% | Added |
| Geode Capital Management, LLC | 150,734 | $572.9K | 0.00% | +19,828+15.1% | Added |
| Takeda Pharmaceutical Co Ltd | 215,172 | $817.7K | 0.35% | −123,507−36.5% | Reduced |
| United Services Automobile Association | 312,095 | $1.19M | 0.03% | −169,205−35.2% | Reduced |
| Alphabet Inc. | 448,492 | $1.70M | 0.09% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 493,584 | $1.88M | 2.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 709,828 | $2.70M | 0.00% | +24,525+3.6% | Added |
| Activest Wealth Management | 0 | $0 | 0.00% | −9,800−100.0% | Sold out |
| Alpha Square Group S, LLC | 0 | $0 | 0.00% | −33,401−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −22,587−100.0% | Sold out |
| RSM US Wealth Management LLC | 0 | $0 | 0.00% | −19,813−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −103−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −39−100.0% | Sold out |